The Swedish pharmaceutical company, Orexo AB, has appointed Robin Wright to its executive management group with responsibility for business and commercial development. Mr. Wright joins Orexo from BioScience Managers Limited, a specialist healthcare fund manager and corporate finance boutique, where he was head of the corporate advisory services. Orexo develops new treatments for respiratory and inflammatory diseases.
Source:
Orexo press release, 9 June 2008.
Copyright Evernow Publishing 2008